Tag: Research

Growth Factor Administration in Pancreatic Cancer Treatment

It is common practice for clinicians to administer granulocyte colony-stimulating factor (G-CSF) — a growth factor used to replenish white blood cell counts — during chemotherapy, but what are its effects on overall survival in patients with pancreatic cancer?  

Tagged with:

University of Pittsburgh Receives Prestigious NIH Award for Research Excellence in Ovarian Cancer

The University of Pittsburgh was awarded a five-year grant from the National Institutes of Health (NIH) to support an Ovarian Cancer Specialized Program of Research Excellence (SPORE). The award is led by Ronald Buckanovich, MD, PhD, and Robert Edwards, MD. Dr. Buckanovich is a professor

Tagged with: ,

Eight UPMC Hillman Cancer Center Members Named Highly Cited Researchers

Clarivate™ has named their list of Highly Cited Researchers for 2023 — an elite group that demonstrates significant and broad influence in their field of research. Each researcher selected has authored multiple Highly Cited Papers™, which rank in the top

Tagged with: ,

Expert Opinions on Breast Cancer Research Innovations

University of Pittsburgh researchers at UPMC Hillman Cancer Center are working to better understand breast cancer to help with the diagnosis, treatment, and prevention of the disease. For example, they are examining the effects of hormones such as estrogen on

Tagged with:

UPMC Hillman Cancer Center ASTRO 2023 Presentations

Saturday, September 30 1:22 – 1:42 p.m. Non Definitive Lung Options: Palliation and XRT Alone Location: Room 33 Uzoma Iheagwara, MD, PhD – UPMC Hillman Cancer Center Sunday, October 1  8 – 9 a.m. SS 02 – GYN 1: Integrating

Tagged with: ,

Enhancing Antitumor Immunity Targeting Regulatory T Cells

Published in Science Immunology, researchers led by Dario Vignali, PhD, distinguished professor and chair of the Department of Immunology and member of UPMC Hillman Cancer Center, identified a genetic mechanism to enhance an immune system’s antitumor activity. By finding a

Tagged with:

Ben Nacev, MD, PhD, Named Damon Runyon Clinical Investigator for his Innovative Sarcoma Research

Benjamin A. Nacev, MD, PhD, assistant professor of medicine in the Division of Hematology/Oncology, has been named a Damon Runyon Clinical Investigator by the Damon Runyon Cancer Research Foundation. With his mentor, Jeremy Rich, MD, Dr. Nacev will receive $600,000

Tagged with: ,

UPMC Hillman Cancer Center ASCO 2023 Presentations

Friday, June 2 Posters Divya Natesan “Differences in real-world pembrolizumab dosing patterns (every 3 weeks versus every 6 weeks) across a large cancer center network” 8 to 11 a.m. Hall A | Abstract 2592 | Board 434 Jingxiao Jin, MD

Tagged with:

Bench to Bedside: The Research Journey of Fecal Microbiota Transplants

Researchers have known that microorganisms in the gut can impact the effectiveness of immunogenic chemotherapies for cancer patients. When studies showed that the same could be true for immune checkpoint inhibitors, it opened the possibility for better treatment options for

Tagged with: ,

Leadership in Head and Neck Cancer

Head and neck cancer accounts for approximately 4% of cancer cases in the U.S. — affecting more than 60,000 people each year. The majority of those diagnosed are over the age of 50, but a rising rate of HPV-associated head

Tagged with: ,
Top